VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Remitch
Preclinical
Small molecule
S
Shandong New Time Pharmaceutical Co., LTD
1
Indications
2
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Pruritus
1 trial
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Recruiting
·
G
Guangdong Provincial People's Hospital
·
N/A
·
NCT07098351
·
93 enrolled
Humans
1 trial
Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans
Completed
·
S
Shandong New Time Pharmaceutical Co., LTD
·
N/A
·
NCT07478133
·
72 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Remitch. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Remitch compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Remitch. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Shandong New Time Pharmaceutical Co., LTD company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
S
Shandong New Time Pharmaceutical Co., LTD
Related News